1.劉新泳, 徐文方等,川芎醇酯類(lèi)衍生物及其制備方法和含有川芎醇酯類(lèi)衍生物的藥物組合物與應(yīng)用。中華人民共和國(guó)國(guó)家知識(shí)產(chǎn)權(quán)局,中國(guó)發(fā)明專(zhuān)利, ZL02135989.X , 2005-1-12
2.劉新泳,徐文方, 程先超等 川芎嗪烴基哌嗪類(lèi)衍生物、制備方法和藥物組合物與應(yīng)用。 中華人民共和國(guó)國(guó)家知識(shí)產(chǎn)權(quán)局, 中國(guó)發(fā)明專(zhuān)利,專(zhuān)利號(hào):ZL200510045307.4,(2007-7-18)
3.劉新泳,徐文方, 閆任章等. 2,4-二取代雜環(huán)并[4,5-e][1,2,4]噻二嗪衍生物制備方法. 中華人民共和國(guó)國(guó)家知識(shí)產(chǎn)權(quán)局。專(zhuān)利號(hào):ZL2006 1 0043834.6 2008-6-11
4. 劉新泳,徐文方等. N4-取代吡唑[4,5-e]]1,2,4]噻二嗪類(lèi)衍生物、制備方法及其藥物組合物與應(yīng)用。 中華人民共和國(guó)國(guó)家知識(shí)產(chǎn)權(quán)局。專(zhuān)利號(hào):ZL200510044297.2 2009-2
5. 劉新泳,徐文方, 林永強(qiáng)等. N1,N3-二取代噻吩并[3,2-e][2,1,3]噻二嗪-2,2,4-三酮類(lèi)衍生物與應(yīng)用。中華人民共和國(guó)國(guó)家知識(shí)產(chǎn)權(quán)局。專(zhuān)利號(hào):ZL 200610043833.1, 2009年6月17日
6. 劉新泳,李錦等. N1,N3-二取代吡唑并[4,5-e][2,1,3]噻二嗪-2,2,4-三酮類(lèi)衍生物及其制備方法與應(yīng)用。專(zhuān)利號(hào):ZL200710015052.6 中華人民共和國(guó)國(guó)家知識(shí)產(chǎn)權(quán)局,2009年7月29
7. 劉新泳等。聚乙二醇修飾齊夫多定綴合物及其制備方法與應(yīng)用,中華人民共和國(guó)國(guó)家知識(shí)產(chǎn)權(quán)局,專(zhuān)利號(hào): ZL200710015587.3, 2010-1-21 。
8.劉新泳等, 川芎嗪茋類(lèi)衍生物、制備方法和藥物組合物與應(yīng)用。中華人民共和國(guó)國(guó)家知識(shí)產(chǎn)權(quán)局,專(zhuān)利號(hào): ZL200710014906.9 , 2010-2-03
9. 劉新泳等, 川芎嗪胍類(lèi)衍生物的制備方法及其應(yīng)用。中華人民共和國(guó)國(guó)家知識(shí)產(chǎn)權(quán)局。申請(qǐng)?zhí)枺?nbsp;ZL200810157518.0 2010-06
1. Peng Zhan, Xinyong Liu*, Zhenyu Li, Zengjun Fang, Zhong Li, Defeng Wang, Christophe Pannecouque, Erik De Clercq. Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: synthesis and preliminary SAR studies. Bioorganic & Medicinal Chemistry, 2009; 17(16): 5920-5927. (15 August 2009).
2. Mingyan Yu, Xinyong Liu*, Zhenyu Li, Shuai Liu, Christophe Pannecouque, Erik De Clercq Synthesis and biological evaluation of novel 2-(substituted phenylaminocarbonyl methylthio)-6-(2,6-dichlorobenzyl)-pyrimidin-4(3H)-ones as potent HIV-1 NNRTIs. Bioorganic & Medicinal Chemistry, 2009;17: 7749–7754
3. Peng Zhan, Xinyong Liu*, Junjie Zhu, Zengjun Fang, Zhenyu Li, Christophe Pannecouque, Erik De Clercq. 1,2,3-Selenadiazole thioacetanilides: Synthesis and anti-HIV activity evaluation Bioorg Med Chem. 2009; 17(16): 5733-6146
4. Peng Zhan, Xinyong Liu*, Junjie Zhu, Zengjun Fang, Zhenyu Li, Christophe Pannecouque, Erik De Clercq. Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. Bioorg Med Chem. 2009; 17(16): 5775-5781.
5. Xinyong Liu*, Peng Zhan, Christophe Pannecouque, Erik De Clercq. Design, Synthesis and Anti-HIV-1 Evaluation of Novel Arylazolylthioacetanilides as Potent NNRTIS. Antiviral Research, Volume 82, Issue 2, May 2009, Pages A44-A45
6. Peng Zhan, Xinyong Liu*, Zengjun Fang, Zhenyu Li, Christophe Pannecouque, Erik De Clercq. Synthesis and anti-HIV activity evaluation of 2-(4-(naphthalen-2-yl)-1,2,3-thiadiazol-5- ylthio)-N-acetamides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. European Journal of Medicinal Chemistry, 2009; 44 : 4648–4653
7.Xian-Chao Cheng, Xin-Yong Liu*, Wen-Fang Xu, Xiu-Li Guo Ning Zhang, Yuning Song Ligustrazine derivatives part 31: Design, synthesis and evaluation of novel acylpiperazinyl derivatives as potential cerebrocardiac vascular agents. Bioorganic & Medicinal Chemistry. 2009; 17: 3018–3024
8. Yuan Cao, Xinyong Liu* and Erik De Clercq. Cessation of HIV-1 Transcription by Inhibiting Regulatory Protein Rev-Mediated RNA Transport. Current HIV Research, 2009, 7(1):, 101-108
9. Yu Mingyan, Liu Xinyong* and Erik De Clercq. NF-κB: The Inducible Factors of HIV-1 Transcription and their Inhibitors. Mini-Reviews in Medicinal Chemistry, 2009, 9(1): 60-69
10. Jiyan Zhang, Xinyong Liu* and Erik De Clercq. Capsid (CA) Protein as a Novel Drug Target: Recent Progress in the Research of HIV-1 CA Inhibitors. Mini-Reviews in Medicinal Chemistry. 2009; Volume 9(4): April, 510-518.
11. Yan Wang, Xin-yong Liu* and Erik De Clercq. Role of the HIV-1 Positive Elongation Factor P-TEFb and Inhibitors Thereof. Mini-Reviews in Medicinal Chemistry, 2009, 9(3): 379-385
12. Peng Zhan and Xinyong Liu*. Designed Multiple Ligands: An Emerging Anti-HIV Drug Discovery Paradigm. Curr Pharm Des. 2009; 36(15): 1893-1917
13. Peng Zhan, Zhenyu Li, Xinyong Liu* Sulfanyltriazole/tetrazoles: A Promising Class of HIV-1 NNRTIs. Mini-Reviews in Medicinal Chemistry, 2009, 9(8): 1014-1023
14. Peng Zhan, Xinyong Liu* and Zhanyu Li. Recent advances in the discovery and development of novel HIV-1 NNRTI platforms: 2006-2008 update. Current Medicinal Chemistry, 2009; 16(22): 2876-2889. (August 2009)
15. Peng Zhan, Xinyong Liu*, Christophe Pannecouque, Erik De Clercq. Design Strategies of Novel NNRTIs to Overcome Drug Resistance. Current Medicinal Chemistry, 2009; 16(29): 3903-3917.